Upon in vitro osteogenic differentiation of n = 2 RANK mutated cases versus n = 2 RANK wild-type MDS cases we observed a higher osteogenic propensity of RANK mutant MSCs as compared to RANK wild-type MDS MSCs (Fig. 3p, q). The gene discussed is TNFRSF11A; the disease is myelodysplastic syndrome.